Loss of proteostasis and cellular senescence are two well-established hallmarks of “normal” ageing, and are linked to almost all major ageing-associated chronic diseases.
We are systematically investigating the inter-dependence of these two ageing hallmarks, with the goal of identifying proteostasis network vulnerabilities that could be exploited therapeutically to modulate the senescent cellular state.
